Five-Year Outcomes Comparable for TAVR, Surgical AVR

TUESDAY, Feb. 4, 2020 -- There is no significant difference in the incidence of death or disabling stroke at five years among patients with aortic stenosis at intermediate surgical risk who undergo transcatheter aortic valve replacement (TAVR) or...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news